"Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.

MLA

Maritati, Federica, et al. “‘Eculizumab First’ in the Management of Posttransplant Thrombotic Microangiopathy.” Kidney International Reports, vol. 9, no. 4, Jan. 2024, pp. 982–93. EBSCOhost, https://doi.org/10.1016/j.ekir.2024.01.013.

APA

Maritati, F., Corradetti, V., Bini, C., Provenzano, M., Cuna, V., Busutti, M., Tondolo, F., Zappulo, F., Vischini, G., Iacovella, F., Abenavoli, C., Borelli, G., Demetri, M., Fabbrizio, B., Radi, G., Ravaioli, M., Mele, C., La Manna, G., & Comai, G. (2024). “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy. Kidney International Reports, 9(4), 982–993. https://doi.org/10.1016/j.ekir.2024.01.013

Chicago

Maritati, Federica, Valeria Corradetti, Claudia Bini, Michele Provenzano, Vania Cuna, Marco Busutti, Francesco Tondolo, et al. 2024. “‘Eculizumab First’ in the Management of Posttransplant Thrombotic Microangiopathy.” Kidney International Reports 9 (4): 982–93. doi:10.1016/j.ekir.2024.01.013.